1. Home
  2. NEOG vs STOK Comparison

NEOG vs STOK Comparison

Compare NEOG & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$11.87

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

BUY

Current Price

$24.18

Market Cap

2.0B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
NEOG
STOK
Founded
1981
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
NEOG
STOK
Price
$11.87
$24.18
Analyst Decision
Buy
Strong Buy
Analyst Count
4
14
Target Price
$14.00
★ $46.46
AVG Volume (30 Days)
★ 3.9M
696.2K
Earning Date
10-06-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 99.20
92.73
EPS
★ N/A
N/A
Revenue
★ $870,400,000.00
$184,420,000.00
Revenue This Year
$1.47
N/A
Revenue Next Year
N/A
$39.98
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 404.50
52 Week Low
$5.37
$20.32
52 Week High
$14.26
$40.22

Technical Indicators

Market Signals
Indicator
NEOG
STOK
Relative Strength Index (RSI) 44.24 29.76
Support Level $8.68 N/A
Resistance Level $12.55 $33.61
Average True Range (ATR) 0.71 1.29
MACD -0.16 -0.20
Stochastic Oscillator 1.90 17.81

Price Performance

Historical Comparison
NEOG
STOK

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: